Your browser doesn't support javascript.
loading
Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells.
Shi, Junfeng; Chen, Yi; Chen, Wenxing; Tang, Cuiju; Zhang, Honghong; Chen, Yuetong; Yang, Xiuwei; Xu, Zhi; Wei, Jingsun; Chen, Jinfei.
Afiliación
  • Shi J; Department of Oncology, Nanjing First Hospital, NanJing Medical University, Nanjing, China.
  • Chen Y; Clinical Research Center, Xuyi People's Hospital, Xuyi, China.
  • Chen W; Department of Oncology, Nanjing Pukou Central Hospital, Nanjing, China.
  • Tang C; School of pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Zhang H; Department of Oncology, Nanjing First Hospital, NanJing Medical University, Nanjing, China.
  • Chen Y; Department of Oncology, Nanjing First Hospital, NanJing Medical University, Nanjing, China.
  • Yang X; Department of Oncology, Nanjing First Hospital, NanJing Medical University, Nanjing, China.
  • Xu Z; Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
  • Wei J; Department of Oncology, Nanjing First Hospital, NanJing Medical University, Nanjing, China.
  • Chen J; Department of Oncology, Nanjing First Hospital, NanJing Medical University, Nanjing, China.
J Cell Mol Med ; 22(11): 5220-5230, 2018 11.
Article en En | MEDLINE | ID: mdl-30179299

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Chalconas / Receptor alfa de Estrógeno / Antineoplásicos Fitogénicos Límite: Female / Humans Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Chalconas / Receptor alfa de Estrógeno / Antineoplásicos Fitogénicos Límite: Female / Humans Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2018 Tipo del documento: Article País de afiliación: China